Salud financiera de hoja de balance de Applied UV

Salud financiera controles de criterios 4/6

Applied UV tiene un patrimonio de los accionistas total de $24.9M y una deuda total de $4.6M, lo que sitúa su ratio deuda-patrimonio en 18.4%. Sus activos y pasivos totales son $58.4M y $33.5M respectivamente.

Información clave

18.4%

Ratio deuda-patrimonio

US$4.59m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	US$1.13m
Patrimonio	US$24.88m
Total pasivo	US$33.50m
Activos totales	US$58.39m

Actualizaciones recientes sobre salud financiera

Recent updates

It's A Story Of Risk Vs Reward With Applied UV, Inc. (NASDAQ:AUVI)

Apr 01

It's A Story Of Risk Vs Reward With Applied UV, Inc. (NASDAQ:AUVI)

Aug 15

Applied UV gains on securing $1.5M purchase order to provide premium furnishings

Sep 08

Applied UV, Inc. (NASDAQ:AUVI) Analysts Are Pretty Bullish On The Stock After Recent Results

Aug 19

Applied UV GAAP EPS of -$0.26 misses by $0.10, revenue of $5.91M beats by $2.24M

Aug 15

Applied UV stock rallies as UVC disinfection platform kills COVID-19 virus

Jun 16

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($17.0M) de AUVI no cubren sus pasivos a corto plazo ($27.9M).

Pasivo a largo plazo: Los activos a corto plazo de AUVI ($17.0M) superan a sus pasivos a largo plazo ($5.6M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (13.9%) de AUVI se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de AUVI ha crecido de 0% a 18.4% en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: AUVI tiene suficiente cash runway para 2 meses según el flujo de caja libre último declarado, pero desde entonces ha obtenido capital adicional.

Pronóstico de cash runway: Se prevé que AUVI disponga de suficiente cash runway para 2 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.

Salud financiera de hoja de balance de Applied UV

Salud financiera controles de criterios 4/6

Información clave

Actualizaciones recientes sobre salud financiera

The Nasdaq Stock Market LLC Determines Applied UV’s Common Stock to be Delisted from Nasdaq, as a Result of the Filings of the Chapter 11 Cases

The Nasdaq Stock Market LLC Determines Applied UV’s Common Stock to be Delisted from Nasdaq, as a Result of the Filings of the Chapter 11 Cases

Motion for Joint Administration Approved for Applied UV, Inc.

Applied UV, Inc. Filed for Bankruptcy

Motion for Joint Administration Filed by Applied UV, Inc.

Applied UV Receives Letter from Nasdaq Regarding Non-Compliance with Minimum Closing Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(2)

Recent updates

The Nasdaq Stock Market LLC Determines Applied UV’s Common Stock to be Delisted from Nasdaq, as a Result of the Filings of the Chapter 11 Cases

The Nasdaq Stock Market LLC Determines Applied UV’s Common Stock to be Delisted from Nasdaq, as a Result of the Filings of the Chapter 11 Cases

Applied UV, Inc.(OTCPK:AUVI.Q) dropped from S&P TMI Index

Applied UV, Inc.(OTCPK:AUVI.Q) dropped from NASDAQ Composite Index

Motion for Joint Administration Approved for Applied UV, Inc.

Applied UV, Inc. Filed for Bankruptcy

Motion for Joint Administration Filed by Applied UV, Inc.

Applied UV Receives Letter from Nasdaq Regarding Non-Compliance with Minimum Closing Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Pursuant to Nasdaq Listing Rule 5550(a)(2)

Applied UV, Inc. Announces Resignation of Eugene Burleson from its Board of Directors and Audit Committee and Appoints Christopher Kochuba as Member of Audit and Compensation Committee

Applied UV, Inc. announced delayed annual 10-K filing

It's A Story Of Risk Vs Reward With Applied UV, Inc. (NASDAQ:AUVI)

Applied UV, Inc. has filed a Follow-on Equity Offering in the amount of $2.763 million.

Applied UV, Inc. Appoints Christopher Kobucha as Member of the Board

Applied UV Inc. Announces Launch of Patented Fighter Flex LED Solution Opening Significant Revenue Opportunity

Applied UV, Inc. has completed a Composite Units Offering in the amount of $6.4 million.

Applied UV, Inc. announced delayed 10-Q filing

New major risk - Share price stability

Applied UV Receives Letter from the Nasdaq Listing Qualifications Staff of the Nasdaq, Regarding Minimum Closing Bid Price

Applied UV, Inc. to Report Q2, 2023 Results on Aug 21, 2023

Applied UV, Inc. announced delayed 10-Q filing

It's A Story Of Risk Vs Reward With Applied UV, Inc. (NASDAQ:AUVI)

Applied UV, Inc. has completed a Follow-on Equity Offering.

New major risk - Shareholder dilution

Applied UV, Inc. to Report Q1, 2023 Results on May 22, 2023

Applied UV, Inc. announced delayed 10-Q filing

Consensus revenue estimates increase by 66%, EPS downgraded

Applied UV, Inc. (NasdaqCM:AUVI) acquired Puro Lighting, LLC from Brian Stern, Andrew Lawrence, Jeff Stern, Bobby Lawrence and James Colantoni for $15.1 million.

Applied UV, Inc. Announces the Resignation of John Andrews as Chief Executive Officer

Applied UV, Inc. (NasdaqCM:AUVI) agree to acquire LED Supply Co., LLC.

Consensus forecasts updated

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to US$5.00

Less than half of directors are independent

Applied UV, Inc. to Report Q3, 2022 Results on Nov 14, 2022

Applied UV gains on securing $1.5M purchase order to provide premium furnishings

Consensus forecasts updated

Applied UV, Inc. (NASDAQ:AUVI) Analysts Are Pretty Bullish On The Stock After Recent Results

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Applied UV GAAP EPS of -$0.26 misses by $0.10, revenue of $5.91M beats by $2.24M

Price target decreased to US$6.80

Less than half of directors are independent

Applied UV, Inc. to Report Q2, 2022 Results on Aug 15, 2022

Applied UV Names Monica Woo to Board of Directors

Applied UV, Inc. Announces Board Changes

Applied UV, Inc. Announces Board Changes

Applied UV, Inc. Adds Monica Woo to Board of Directors

Applied UV, Inc. to Report Q1, 2022 Results on May 23, 2022

Applied UV, Inc. announced delayed 10-Q filing

Applied UV, Inc Appoints John F. Andrews as Chief Executive Officer

Applied UV, Inc Appoints John F. Andrews as Member of the Board of Directors

Applied UV, Inc., Annual General Meeting, May 17, 2022

Applied UV, Inc. announced delayed annual 10-K filing

Applied UV Receives Letter from Nasdaq Indicating That the Company Is Not in Compliance with Nasdaq Rule 5620

Price target decreased to US$10.88

Applied UV, Inc. has completed a Follow-on Equity Offering in the amount of $8.000001 million.

President & Director recently bought US$50k worth of stock

Third quarter 2021 earnings released: US$0.12 loss per share (vs US$0.14 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.23 loss per share (vs US$0.06 loss in 2Q 2020)

President & Director notifies of intention to sell stock

Applied UV stock rallies as UVC disinfection platform kills COVID-19 virus

Consensus forecasts updated

Consensus revenue estimates increase to US$12.0m

First quarter 2021 earnings released: US$0.11 loss per share (vs US$0.004 loss in 1Q 2020)

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera